Slingshot members are tracking this event:
Gilead (GILD) Expects to Submit New Drug Application for HIV-1 Infection Single Tablet Regimen Bictegravir (B/F/TAF) to FDA in Q3 2017
Slingshot Insights Explained
Jun 12, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords New Drug Application, Hiv-1 Infection, Bictegravir, Tenofovir Alafenamide, Emtricitabine, B/f/taf